# clm_F6EB021B631B

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: cash_and_equivalents  
value: 3,369,000,000 United States dollar  
valid_from: 2024-09-30  
valid_to: 2024-12-31  
published: 2024-10-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_DBC8478F7F2C  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company cash and equivalents: 3,369,000,000 United States dollar", as of 2024-09-30 (until 2024-12-31). Claim clm_F6EB021B631B, https://asof.is/claim/clm_F6EB021B631B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947824000245/0000059478-24-000245-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-10-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947824000245/0000059478-24-000245-index.htm (primary, SEC EDGAR 10-Q Q3 FY2024, published 2024-10-30)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | cash_and_equivalents | 3,223,600,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_F6EB021B631B](/claim/clm_F6EB021B631B.md) | [clm_EB5CDAC12500](/claim/clm_EB5CDAC12500.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.